首頁 > 市場調查報告書 > 製藥

非專利藥糖尿病生技仿製藥

市場調查報告書

商品編碼

1767702

按年齡層、強度、劑型、最終用戶、分銷管道和地區分類的 Lantus 市場

Lantus Market, By Age Group, By Strength, By Dosage Form, By End User, By Distribution Channel, By Geography

出版日期: 2025年06月27日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

蘭塔斯市場規模預計在 2025 年達到 21.1 億美元，預計到 2032 年將達到 31.4 億美元，2025 年至 2032 年的複合年成長率為 5.84%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	21.1億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	5.84%	2032年價值預測	31.4億美元

全球 Lantus 市場是糖尿病藥物的關鍵領域，專注於長效胰島素製劑，旨在為第 1 型和第 2 型糖尿病患者提供持續的血糖控制。 Lantus（Insulin Glargine）是一種合成的長效基礎胰島素類似物製劑，可模擬人體的自然胰島素分泌模式，每日一次給藥即可提供 24 小時血糖控制。市面上有各種劑型，包括管瓶和預填充筆，可滿足不同患者的偏好和全球醫療保健提供系統的需求。這個市場的重要性歸因於全球糖尿病盛行率的不斷上升，糖尿病影響著全球超過 5.37 億成年人，預計未來幾十年將大幅增加。胰島素輸送系統的技術進步，加上病患遵從性和治療效果的改善，使 Lantus 成為糖尿病管理通訊協定的基石療法。市場動態受到專利到期、生物相似藥競爭、法規結構、醫療保健基礎設施發展以及強調個人化糖尿病治療方法以實現最佳患者療效的新興市場治療指南等因素的影響。

市場動態

全球Lantus市場受到多個關鍵促進因素的支撐，這些因素持續塑造其成長軌跡。關鍵促進因素包括全球糖尿病疫情的惡化，尤其是第2型糖尿病，其主要原因是久坐不動的生活方式、飲食習慣的改變以及已開發經濟體和新興經濟體肥胖率的上升。 Lantus卓越的藥物動力學特性促進了醫生的偏好和患者的接受，因為與傳統胰島素製劑相比，它能夠提供更低的胰島素峰值作用和更少的低血糖發作。同時，包括智慧胰島素筆和連網型設備在內的給藥機制的持續創新提高了治療依從性和監測能力。然而，該市場面臨專利懸崖的重大阻礙因素，為生物相似藥的競爭打開了大門，並顯著影響了定價策略和市場佔有率動態。同時，新製劑和給藥系統的嚴格監管核准流程也成為市場進入和擴張的障礙。此外，控制醫療成本的壓力（尤其是在新興市場），以及複雜的報銷制度和不同的保險覆蓋政策，限制了市場准入和市場發展潛力。儘管面臨這些挑戰，糖尿病盛行率仍在快速上升，但在亞太、拉丁美洲和非洲等新興市場，治療滲透率仍然較低，這帶來了尚未開發的市場潛力。持續血糖監測系統和人工智慧糖尿病管理平台等數位健康技術的整合，為改善患者預後和實現市場差異化提供了機會。同時，人們對糖尿病併發症和血糖控制重要性的認知不斷提高，推動了已開發經濟體和新興經濟體醫療保健體系對來得時等高階胰島素治療產品的需求。

本研究的主要特點

本報告對全球 Lantus 市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模（以十億美元為單位）和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、性能和策略等參數概述了全球 Lantus 市場的主要企業。
主要企業包括賽諾菲。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球 Lantus 市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
透過用於分析全球蘭塔斯市場的各種策略矩陣，相關人員將發現決策更加容易。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 2.11 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.84%	2032 Value Projection:	USD 3.14 Bn

The global Lantus market represents a critical segment within the diabetes therapeutics landscape, focusing on long-acting insulin formulations designed to provide sustained glycemic control for patients with Type 1 and Type 2 diabetes mellitus. Lantus (insulin glargine) is a synthetic, long-acting basal insulin analog that mimics the body's natural insulin production pattern, offering 24-hour glucose control with once-daily dosing. This market encompasses various formulations including vials, pre-filled pens, catering to diverse patient preferences and healthcare delivery systems globally. The market's significance stems from the growing prevalence of diabetes worldwide, affecting over 537 million adults globally, with projections indicating substantial increases in the coming decades. Technological advancements in insulin delivery systems, coupled with improved patient compliance and outcomes, have positioned Lantus as a cornerstone therapy in diabetes management protocols. The market dynamics are influenced by factors including patent expirations, biosimilar competition, regulatory frameworks, healthcare infrastructure development, and evolving treatment guidelines that emphasize personalized diabetes care approaches for optimal patient outcomes.

Market Dynamics

The global Lantus market is propelled by several key drivers that continue to shape its growth trajectory, with the primary catalyst being the escalating global diabetes epidemic, particularly Type 2 diabetes, driven by sedentary lifestyles, dietary changes, and increasing obesity rates across developed and emerging economies. The superior pharmacokinetic profile of Lantus, offering peak less insulin action and reduced hypoglycemic episodes compared to conventional insulin formulations, drives physician preference and patient adoption, while continuous innovation in delivery mechanisms including smart insulin pens and connected devices enhances treatment adherence and monitoring capabilities. However, the market faces significant restraints including patent cliff challenges that have opened doors for biosimilar competition, substantially impacting pricing strategies and market share dynamics, while stringent regulatory approval processes for new formulations and delivery systems create barriers to market entry and expansion. Additionally, healthcare cost containment pressures, particularly in developed markets, along with complex reimbursement landscapes and varying insurance coverage policies, limit market accessibility and growth potential. Despite these challenges, substantial opportunities emerge from expanding healthcare infrastructure in emerging markets across Asia-Pacific, Latin America, and Africa, where diabetes prevalence is rising rapidly but treatment penetration remains low, creating untapped market potential. The integration of digital health technologies, including continuous glucose monitoring systems and artificial intelligence-driven diabetes management platforms, presents opportunities for enhanced patient outcomes and market differentiation, while growing awareness about diabetes complications and the importance of glycemic control drives demand for premium insulin therapies like Lantus in both developed and developing healthcare systems.

Key Features of the Study

This report provides in-depth analysis of the global Lantus market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global Lantus market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key company covered as a part of this study include Sanofi.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global Lantus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Lantus market.

Market Segmentation

Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adult
Strength Insights (Revenue, USD Bn, 2020 - 2032)
- 10 mL
- 3 mL
Dosage Form Insights (Revenue, USD Bn, 2020 - 2032)
- Multi-dose Vial
- Single Patient use Prefilled pen
End User Insights (Revenue, USD, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Long-Term Care Facilities
- Others (Home Care Settings, etc.)
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Sanofi

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Lantus Market, By Age Group
- Global Lantus Market, By Strength
- Global Lantus Market, By Dosage Form
- Global Lantus Market, By End User
- Global Lantus Market, By Distribution Channel
- Global Lantus Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trends
Epidemiology
Treatment Option Analysis
Price Differentiation Analysis (Lantus and Biosimilars)
Reimbursement Scenario
Adherence and Switch Rate Analysis in U.S.
Disease Awareness Programs

4. Global Lantus Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Lantus Market, By Strength, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
10 mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
3 mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Lantus Market, By Dosage Form, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Multi-dose Vial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Single Patient use Prefilled pen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Lantus Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Long-Term Care Facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Home Care Settings, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Lantus Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Lantus Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

胰島素生物相似藥市場規模、佔有率、成長分析（按類型、適應症、分銷管道和地區）- 產業預測，2025-2032 年

胰島素生物相似藥市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、疾病適應症類型、配銷通路、最終用戶、地區和競爭細分，2019-2029F

FAQ

按年齡層、強度、劑型、最終用戶、分銷管道和地區分類的 Lantus 市場

Lantus Market, By Age Group, By Strength, By Dosage Form, By End User, By Distribution Channel, By Geography

市場動態

目錄

第1章調查目的與前提條件

第2章市場展望

第3章市場動態、法規與趨勢分析

4. 2020 年至 2032 年按年齡分類的全球 Lantus 市場

5.全球Lantus 市場（依實力分類），2020 年至 2032 年

6. 2020 年至 2032 年全球 Lantus 市場（依劑型分類）

7.全球Lantus 市場（以最終用戶分類），2020 年至 2032 年

8.全球Lantus 市場（依分銷管道分類），2020 年至 2032 年

第9章。 2020 年至 2032 年按地區分類的全球 Lantus 市場

第10章競爭格局

第 11 章分析師建議

第12章參考文獻與調查方法